170 related articles for article (PubMed ID: 984795)
1. Synergy of mecillinam, a beta-amidinopenicillanic acid derivative, combined with beta-lactam antibiotics.
Neu JC
Antimicrob Agents Chemother; 1976 Sep; 10(3):535-42. PubMed ID: 984795
[TBL] [Abstract][Full Text] [Related]
2. Mecillinam, a novel penicillanic acid derivative with unusual activity against gram-negative bacteria.
Neu HC
Antimicrob Agents Chemother; 1976 May; 9(5):793-9. PubMed ID: 949176
[TBL] [Abstract][Full Text] [Related]
3. Synergy of mecillinam (FL1060) with penicillins and cephalosporins against Proteus and Klebsiella, with observations on combinations with other antibiotics and against other bacterial species.
Baltimore RS; Klein JO; Wilcox C; Finland M
Antimicrob Agents Chemother; 1976 Apr; 9(4):701-5. PubMed ID: 1267442
[TBL] [Abstract][Full Text] [Related]
4. Mecillinam--an amidino penicillin which acts synergistically with other beta-lactam compounds.
Neu HC
J Antimicrob Chemother; 1977 Jul; 3 Suppl B():43-52. PubMed ID: 893247
[No Abstract] [Full Text] [Related]
5. Mecillinam (FL 1060), a 6beta-amidinopenicillanic acid derivative: in vitro evaluation.
Tybring L
Antimicrob Agents Chemother; 1975 Sep; 8(3):266-70. PubMed ID: 241287
[TBL] [Abstract][Full Text] [Related]
6. Activity of mecillinam alone and in combination with other beta-lactam antibiotics.
Fass RJ
Antimicrob Agents Chemother; 1980 Dec; 18(6):906-12. PubMed ID: 6263179
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae.
Shah PP; Briedis DJ; Robson HG; Conterato JP
Antimicrob Agents Chemother; 1979 Mar; 15(3):346-50. PubMed ID: 111609
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of the activity of cefamandole and other cephalosporins and analysis of the beta-lactamase stability and synergy of cefamandole with aminoglycosides.
Fu KP; Neu HC
J Infect Dis; 1978 May; 137 Suppl():S38-S50. PubMed ID: 349097
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens.
Miller MA; Yousuf M; Griffin PS; Bartlett M; Crane JK
Microbiol Immunol; 1979; 23(10):955-64. PubMed ID: 390321
[TBL] [Abstract][Full Text] [Related]
10. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Hall WH; Opfer BJ; Gerding DN
Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
Fass RJ
Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the epidemiology of bacterial resistance to mecillinam and ampicillin.
Anderson JD; Adams MA; Barrington JC; Spence WN; Sheperd CA
Antimicrob Agents Chemother; 1976 Dec; 10(6):872-7. PubMed ID: 1051328
[TBL] [Abstract][Full Text] [Related]
13. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Giamarellou H
Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
[TBL] [Abstract][Full Text] [Related]
14. Comparison of in vitro activities of eight new beta-lactam compounds against cephalothin-resistant Enterobacteriaceae from hospital patients.
Costopoulos C; Legakis NJ; Papafragas E; Marinis E
Chemotherapy; 1984; 30(3):158-64. PubMed ID: 6610538
[TBL] [Abstract][Full Text] [Related]
15. Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins.
Neu HC; Fu KP
Antimicrob Agents Chemother; 1978 May; 13(5):813-9. PubMed ID: 666302
[TBL] [Abstract][Full Text] [Related]
16. Piperacillin, a new penicillin active against many bacteria resistant to other penicillins.
Fu KP; Neu HC
Antimicrob Agents Chemother; 1978 Mar; 13(3):358-67. PubMed ID: 122519
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility to penicillin derivatives among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
Mischnik A; Baumert P; Hamprecht A; Rohde A; Peter S; Feihl S; Knobloch J; Gölz H; Kola A; Obermann B; Querbach C; Willmann M; Gebhardt F; Tacconelli E; Gastmeier P; Seifert H; Kern WV;
Diagn Microbiol Infect Dis; 2017 Jan; 87(1):71-73. PubMed ID: 27769572
[TBL] [Abstract][Full Text] [Related]
18. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.
Jones RN; Thornsberry C; Barry AL; Fuchs PC; Gavan TL; Gerlach EH
J Antibiot (Tokyo); 1977 Dec; 30(12):1107-14. PubMed ID: 599084
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro appraisal of piperacillin, including its activity against Salmonella typhi.
Robinson RG; Saunders J; Cassel R; Block CS; Koornhof HJ
Antimicrob Agents Chemother; 1980 Oct; 18(4):493-501. PubMed ID: 6449903
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of pseudomonas to four beta-lactamantibiotics (ampicillin, cephalothin, carbenicillin, piperacillin), to four aminoglycosides (kanamycin, amikacin, gentamicin, tobramycin) and to colimycin.
Hoogkamp-Korstanje JA; Westerdaal NA
Chemotherapy; 1979; 25(1):48-53. PubMed ID: 253637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
